The management of pre-invasive disease of the cervix is based on local cont
rol and prevention of progression to invasive malignancy. Screening continu
es to be an effective tool for detecting cervical neoplasia in a pre-invasi
ve state due to the long natural history of progression from low-grade dysp
lasia to invasion. When abnormal cells are detected with a Papanicolaou (Pa
p) smear, a thorough evaluation should consist of colposcopy, directed biop
sy, and cone biopsy, where appropriate. In the absence of invasion, local c
ontrol may be achieved by excisional or ablative techniques including tradi
tional cold-knife cone, laser cone, loop electrosurgical excision, cryother
apy, laser or electrocoagulation diathermy. The benefit of excisional thera
py is the ability for histologic specimen assessment. Ablative therapies ar
e associated with lower complication rates (<2%). Success rates for these m
odalities are comparable, exceeding 90%. Eradication of human papilloma vir
us (HPV) from the genitourinary tract [associated with over 90% of condylom
as, cervical intraepithelial neoplasia (CIN) and invasive malignancies] is
not possible with currently available techniques. Semin. Surg. Oncol. 16:22
2-227, 1999. (C) 1999 Wiley-Liss, Inc.